#signaldetection نتائج البحث
🔍 S4 – Stepping Back into the Future of Signal DetectionChaired by UMC & ISoP ⭐ Ronnie Meyboom Lecture – Pitfalls of Disproportionality Analysis @ISoPonline #ISoP2025Cairo #Pharmacovigilance #SignalDetection #DrugSafety #MedicationSafety
Are you identifying potential safety issues related to a drug early enough in your #ClinicalTrial? #SignalDetection is vital in establishing drug and clinical trial #safety. Signal Detection identifies signals that suggest adverse side effects from the trial drug, allowing…
Disproportionality analysis publications have risen sharply since 2022 but transparent and standardised reporting is lacking. Michele Fusaroli presents the READUS-PV guidelines for reporting of disproportionality analysis, endorsed by key journals and publishers. #SignalDetection
#EnterpriseAgility and #SignalDetection: “Enterprise agility relies on rapidly detecting and responding to signals and changes in market trends, customer needs, and technological advancements.” — Scott M. Graffius 🔎 scottgraffius.com/blog/files/cli… #Agile #MarketTrends #Technology
Olivia Mahaux @GSK provides an overview of quantitative signal detection and how embracing a multimodal approach would permit more efficient use of ICSRs #SignalDetection #pharmacovigilance
Niklas Noren @UMCGlobalSafety updates the Signal Detection conference on development of guidance for use of AI in #Pharmacovigilance by CIOMS Working Group XIV, which will be released for public consultation in 2025 and finalised by the end of the year. #SignalDetection
Andrew Bate shares some experimental examples of generative AI in signal detection and discusses the need for caution before wider deployment #SignalDetection#pharmacovigilance
Florence van Hunsel updates delegates at the Signal Detection conference on recent initiatives at Lareb, including development of AI models to help predict which ICSRs need to be clinically assessed. #SignalDetection#pharmacovigilance
Igho Onakpoya @UniofOxford presents a clinical perspective on signal detection, emphasising responsibilities to patients and the need to improve trial design, reporting and physician training #SignalDetection #pharmacovigilance
Amy Bobbins @DSRUDrugSafety presents a case study of validating a signal of congenital anomalies and highlights some of the challenges of using Vigibase to investigate drug exposure during pregnancy #SignalDetection #pharmacovigilance
At today’s Signal Detection conference, Sarah Vaughan @MHRAgovuk provides an update on enhancing the UK’s Yellow Card system to improve user experience, increase transparency and boost utility for signal detection #SignalDetection#pharmacovigilance
#pharmacovigilance #signaldetection ‘Stems’ mark pharmacological relationships between substances and form the backbone of the INN system. Implementation of stem-based post-marketing surveillance could enhance signal-detection efficiency link.springer.com/article/10.100…
Saad Shakir argues that we should ask how AI can serve #Pharmacovigilance, rather than how pharmacovigilance can be fitted into AI capabilities, at today’s Signal Detection conference dsru.org/conference/bie… #SignalDetection
Don’t miss Sandeep Dhanda’s presentation at #ISPEAnnual2025 on evaluation of congenital abnormality signal using VigiBase data + systematic review #Pharmacovigilance #SignalDetection #DrugSafety #DSRU #ISPE2025
Sarah Vaughan @MHRAgovuk covers novel ways to approach signal detection to address current challenges and keep pace with change for both drugs and devices, during her keynote talk at our Signal Detection conference. #SignalDetection #pharmacovigilance
How should disproportionality scores be appropriately reported in articles? We’re pleased that Michele Fusaroli will present the development of the READUS-PV guidelines for reporting disproportionality analyses at our #SignalDetection conference. Book now: bit.ly/4fhMu5C
Our Signal Detection conference is underway, following yesterday’s intensive pre-conference tutorial day. Andrew Bate @GSK kicks off with an overview of signal detection in 2024, including key achievements and the scientific journey to date. #SignalDetection#pharmacovigilance
Signal Detection and Enterprise Agility “Enterprise agility relies on rapidly detecting and responding to signals and changes in market trends, customer needs, and technological advancements.” — Scott M. Graffius, scottgraffius.com/blog/files/cli… #SignalDetection #EnterpriseAgility
Stop drowning in dashboards and start seeing signals. Snowfire filters the noise, surfaces what matters, and helps you act in under 24 hours. 👉 bit.ly/47X0Xma #Analytics #SignalDetection #SaaS #BusinessIntelligence
#pharmacovigilance #signaldetection ‘Stems’ mark pharmacological relationships between substances and form the backbone of the INN system. Implementation of stem-based post-marketing surveillance could enhance signal-detection efficiency link.springer.com/article/10.100…
When every minute matters, your agents need updated facts. The #Factiva Retrieval API empowers AI tools to: - Detect. - Verify. - Respond. Learn more: bit.ly/3J7q77q #SignalDetection
6/ We published a mathematical detection method: RIS-13 SETI Decoder 10.5281/zenodo.17141702 It doesn't look for modulation. It looks for coherence: The mathematical signature of conscious mind. zenodo.org/records/171417… #OpenScience #SignalDetection
𝑺𝒎𝒂𝒍𝒍 𝒄𝒐𝒉𝒐𝒓𝒕𝒔. 𝑳𝒊𝒎𝒊𝒕𝒆𝒅 𝒆𝒗𝒊𝒅𝒆𝒏𝒄𝒆. 𝑪𝒐𝒎𝒑𝒍𝒆𝒙 𝒔𝒂𝒇𝒆𝒕𝒚 𝒒𝒖𝒆𝒔𝒕𝒊𝒐𝒏𝒔. How do you even begin? Visit: tinyurl.com/2744unmb #Pharmacovigilance #SignalDetection #RareDiseases #PatientSafety #DDReg
Don’t miss Sandeep Dhanda’s presentation at #ISPEAnnual2025 on evaluation of congenital abnormality signal using VigiBase data + systematic review #Pharmacovigilance #SignalDetection #DrugSafety #DSRU #ISPE2025
Heading to #ISPEAnnual2025 in Washington DC? Sandeep Dhanda will present our signal evaluation on congenital abnormality using VigiBase data + systematic review. Read more: dsru.org/dsrunews/dsru-… #Pharmacovigilance #SignalDetection #DrugSafety #DSRU #ISPE2025
#AgileLeadership and #SignalDetection “Enterprise agility relies on rapidly detecting and responding to signals and changes in market trends, customer needs, and technological advancements.” — Scott M. Graffius Source: scottgraffius.com/blog/files/cli… #Agile #AI #DigitalIntelligence
Agile Leadership “Enterprise agility relies on rapidly detecting and responding to signals and changes in market trends, customer needs, and technological advancements.” — Scott M. Graffius, scottgraffius.com/blog/files/cli… #Agile #SignalDetection #EnterpriseAgility #AgileLeadership
🔍 S4 – Stepping Back into the Future of Signal DetectionChaired by UMC & ISoP ⭐ Ronnie Meyboom Lecture – Pitfalls of Disproportionality Analysis @ISoPonline #ISoP2025Cairo #Pharmacovigilance #SignalDetection #DrugSafety #MedicationSafety
NewTn - SAFETY 3월 무료 교육에 초대합니다! 🗓️ 일정: 2025.03.13 오후 3시 (온라인) 📌 모집: zurl.co/z5x9F 현업에 바로 적용할 수 있는 실무 교육에 참여하고 싶다면 지금 바로 신청하세요! #drugsafety #pharmacovigilance #signaldetection #newtn #ICSR #PBRER #DSUR
#EnterpriseAgility and #SignalDetection: “Enterprise agility relies on rapidly detecting and responding to signals and changes in market trends, customer needs, and technological advancements.” — Scott M. Graffius 🔎 scottgraffius.com/blog/files/cli… #Agile #MarketTrends #Technology
Olivia Mahaux @GSK provides an overview of quantitative signal detection and how embracing a multimodal approach would permit more efficient use of ICSRs #SignalDetection #pharmacovigilance
Medicinal #ProductSafety teams are under pressure to control caseloads, new types of #SignalDetection data, and changing regulations. New efficiencies must be gained without sacrificing quality, security, or #DataPrivacy. Learn more from @OracleHealthSci: social.ora.cl/60163T4ju
Niklas Noren @UMCGlobalSafety updates the Signal Detection conference on development of guidance for use of AI in #Pharmacovigilance by CIOMS Working Group XIV, which will be released for public consultation in 2025 and finalised by the end of the year. #SignalDetection
𝑺𝒎𝒂𝒍𝒍 𝒄𝒐𝒉𝒐𝒓𝒕𝒔. 𝑳𝒊𝒎𝒊𝒕𝒆𝒅 𝒆𝒗𝒊𝒅𝒆𝒏𝒄𝒆. 𝑪𝒐𝒎𝒑𝒍𝒆𝒙 𝒔𝒂𝒇𝒆𝒕𝒚 𝒒𝒖𝒆𝒔𝒕𝒊𝒐𝒏𝒔. How do you even begin? Visit: tinyurl.com/2744unmb #Pharmacovigilance #SignalDetection #RareDiseases #PatientSafety #DDReg
Disproportionality analysis publications have risen sharply since 2022 but transparent and standardised reporting is lacking. Michele Fusaroli presents the READUS-PV guidelines for reporting of disproportionality analysis, endorsed by key journals and publishers. #SignalDetection
Medicinal #ProductSafety teams are under pressure to control caseloads, new types of #SignalDetection data, and changing regulations. New efficiencies must be gained without sacrificing quality, security, or #DataPrivacy. Learn more from @OracleHealthSci: social.ora.cl/60133kEdd
Don’t miss Sandeep Dhanda’s presentation at #ISPEAnnual2025 on evaluation of congenital abnormality signal using VigiBase data + systematic review #Pharmacovigilance #SignalDetection #DrugSafety #DSRU #ISPE2025
Igho Onakpoya @UniofOxford presents a clinical perspective on signal detection, emphasising responsibilities to patients and the need to improve trial design, reporting and physician training #SignalDetection #pharmacovigilance
Amy Bobbins @DSRUDrugSafety presents a case study of validating a signal of congenital anomalies and highlights some of the challenges of using Vigibase to investigate drug exposure during pregnancy #SignalDetection #pharmacovigilance
🔍 Stepping Back into the Future — Join @FusaroliMichele (@UMCGlobalSafety) at #ISoP2025Cairo as he explores what's next in signal detection. 📅 Early Bird: 15 Aug 🔗 Register: isop2025cairo.org/Registration/ @ISoPonline #Pharmacovigilance #SignalDetection #DrugSafety
Andrew Bate shares some experimental examples of generative AI in signal detection and discusses the need for caution before wider deployment #SignalDetection#pharmacovigilance
Medicinal #ProductSafety teams are under pressure to control caseloads, new types of #SignalDetection data, and changing regulations. New efficiencies must be gained without sacrificing quality, security, or #DataPrivacy. Learn more from @OracleHealthSci: social.ora.cl/60113R5gT
Medicinal #ProductSafety teams are under pressure to control caseloads, new types of #SignalDetection data, and changing regulations. New efficiencies must be gained without sacrificing quality, security, or #DataPrivacy. Learn more from @OracleHealthSci: social.ora.cl/60123kEPu
Florence van Hunsel updates delegates at the Signal Detection conference on recent initiatives at Lareb, including development of AI models to help predict which ICSRs need to be clinically assessed. #SignalDetection#pharmacovigilance
Discover how #AI is transforming the #drugsafety landscape, making processes more efficient and ensuring compliance with regulatory standards. Our latest blog dives deep into the innovative applications of AI in case management and #signaldetection. datafoundry.ai/2021/11/ai-for…
Something went wrong.
Something went wrong.
United States Trends
- 1. #StrangerThings5 240K posts
- 2. Thanksgiving 668K posts
- 3. BYERS 53.9K posts
- 4. robin 89.7K posts
- 5. Reed Sheppard 5,689 posts
- 6. Afghan 282K posts
- 7. Podz 4,336 posts
- 8. holly 63K posts
- 9. Dustin 88.8K posts
- 10. National Guard 657K posts
- 11. Vecna 57.2K posts
- 12. hopper 15.6K posts
- 13. Jonathan 73.8K posts
- 14. Gonzaga 8,460 posts
- 15. Lucas 82.4K posts
- 16. Erica 17K posts
- 17. noah schnapp 8,787 posts
- 18. Nancy 67.1K posts
- 19. Tini 9,324 posts
- 20. Joyce 31.2K posts